• Zepbound for Sleep Apnea: FDA Approves First Drug Treatment Option

  • Dec 23 2024
  • Length: 16 mins
  • Podcast

Zepbound for Sleep Apnea: FDA Approves First Drug Treatment Option

Listen for free

View show details

  • Summary

  • Send us a message with this link, we would love to hear from you. Standard message rates may apply.

    This week, we're discussing a significant development in the treatment of obstructive sleep apnea (OSA). The FDA has recently approved Zepbound, a medication used in combination with diet and exercise, as the first drug option for moderate to severe OSA in adults with obesity. We'll break down how Zepbound works by targeting hormones that reduce appetite, which leads to weight loss, and how this can improve OSA symptoms. We'll also explore the details of the clinical trials that led to this approval, including how they measured the medication's effectiveness and what potential side effects patients should be aware of.



    Support the show

    Production and Content: Edward Delesky, MD & Nicole Aruffo, RN
    Artwork: Olivia Pawlowski
    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Zepbound for Sleep Apnea: FDA Approves First Drug Treatment Option

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available